Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2024PharmaceuticalsOpen Access

Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future Perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

SISara IachettiniABAnnamaria BiroccioPZPasquale Zizza

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Iachettini et al. (2024) studied this question.

synapsesocial.com/papers/68e64d72b6db6435875de2e7https://doi.org/10.3390/ph17060771
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling2024 · 22 citations
  2. 25′UTR G-quadruplex structure enhances translation in size dependent manner2024 · 27 citations
  3. 3Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities2014 · 40 citations
  4. 4TMPyP4 promotes cancer cell migration at low doses, but induces cell death at high doses2016 · 63 citations